BookSven Stegemann, editor.
Contents:
Healthcare provision in an aging society: US perspective
Healthcare provision in an aging society: European perspective
Healthcare provision in an aging society: Japanese perspective
Old, Very Old, and Frail
Age and the process of aging
Comprehensive Geriatric Assessment
Patients' clinical characteristics, disease, experience, and perception
Ethical considerations in performing clinical trials in and for older people
Patient reported outcomes from a clinical to a therapeutic tool
Pharmacokinetic and Pharmacodynamic Considerations in the Elderly Population
The Expectation of a Treatment Model: A framework for adherence and Effectiveness
Pharmacoepidemiology and pharmacovigilance for safety and efficacy in older people
Defining patient centric drug product design and its impact on improving safety and effectiveness
Dosing considerations in older adults
Oral Drug Product Use in the Elderly Patient Population
Drug product development for older adults
multiparticulate formulations
Considerations for topical and transdermal drug delivery in older adults
Injectable drug delivery for older patients
Inhalation and Nasal Formulations
Ophthalmic drug development and the elderly
Developing drug administration devices for use by older patients
Manufacturing Platforms for Patient-Centric Drug Products
Novel Manufacturing Technologies for the Production of Patient-Centric Drug Products
Prescribing to Older Adults
Multimorbidity and Polypharmacy
Vaccination in Older Adults
Medication Reviews in Older Adults
The Personalization of Drug therapy for Elderly patients
Importance of Clinical Nutrition in Therapy to Older Adults
Managing drug therapy of older patients in primary and secondary care
Medication adherence and monitoring
Medication compounding in the provision of drug therapy
Geriatric Pharmacotherapy: Optimisation through integrated approach in the hospital setting
European Medicines Agency (EMA): Regulatory perspectives on geriatric medicines
Views on the Therapeutic Needs of Older Adults
Future Perspectives in drug therapy of older people
Opportunities in drug product development in an aging population.